CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML.



Lucas, Claire M, Scott, Laura J, Carmell, Natasha, Holcroft, Alison K, Hills, Robert K, Burnett, Alan K and Clark, Richard E ORCID: 0000-0002-1261-3299
(2018) CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML. Blood advances, 2 (9). 964 - 968.

[img] Text
964.full.pdf - Published Version

Download (812kB)
Item Type: Article
Uncontrolled Keywords: Humans, Carrier Proteins, Membrane Proteins, Nuclear Proteins, Autoantigens, Phosphorylation, Adult, Middle Aged, Female, Male, Proto-Oncogene Proteins c-akt, Leukemia, Myeloid, Acute, Protein Phosphatase 2, Biomarkers, Tumor
Depositing User: Symplectic Admin
Date Deposited: 19 Jul 2018 10:20
Last Modified: 28 Nov 2019 13:01
DOI: 10.1182/bloodadvances.2017013615
URI: http://livrepository.liverpool.ac.uk/id/eprint/3023905
Repository Staff Access